Clash over how to get the most from your healthcare rand
At a conference this week, medical schemes, hospitals and doctors blamed each other for the ills that scheme members encounter with their cover.
July 28, 2007
By Laura du Preez
Amid its own secret profits scandal, highly polarised views, some bickering and a number of genuine attempts to offer solutions, the medical schemes industry met this week to discuss issues arising from how schemes spend the R66 billion a year you contribute to them.
More than 800 representatives of medical schemes, administrators, doctors, managed-care entities, hospitals and pharmaceutical com-panies, as well as brokers, met in Sun City for the Board of Healthcare Funders (BHF) annual conference. The theme of this year's meeting was "Squaring the circle", and reaching consensus on how to cure the ills of the medical schemes industry did prove to be elusive.
Dr Rajesh Patel, the head of the benefit and risk department of the BHF, announced that medical schemes will spend R2 billion this year to cover the cost of the secret mark-ups - or off-invoice rebates - private hospitals make on medical devices and materials.
Days later, Discovery Health, which administers the country's largest open medical scheme, produced evidence it had gathered of the mark-ups on syringes, swabs, surgeons' gowns, catheters and the like that ranged from 1 160 percent to 400 percent.
Two large hospital groups, MediClinic and Life Health, denied involvement in the mark-ups, but a third large group, Netcare, said the rebates it receives on medical devices and materials are no more than 50 percent.
Netcare says it uses the rebates it receives on devices and materials to subsidise the ward and theatre fees it charges. This is the same argument the private hospitals used to justify raising their ward and theatre fees after the medicine pricing regulations stopped them from making profits on the medicines used in hospitals.
Netcare denies it is making super-profits, claiming its modest returns are lower than those made by other healthcare roleplayers such as the surgical device, pharmaceutical and medical scheme administration industries.
However, the high fees that private hospitals charge are being investigated by the Department of Health and the Competition Commission, the conference heard.
Afterwards, Health Minister Dr Manto Tshabalala-Msimang issued a statement noting her department's concern about the rebates on medical devices and materials, and Patrick Masobe, the Registrar of Medical Schemes, says he will meet Discovery about it next week.
Full story from Personal Finance here
Did you like this article? Share it with your favourite social network.